“…[25] The TEM, in a complementary fashion to the TFTbinding assays, showed an increased inhibitory effect on fibrillation with increasing concentration and generation number of PAMAM dendrimers. These findings are consistent with previously published data, [14,[16][17][18]25,26] , suggesting that modulation of the surface charge of the protein or peptide by a dendrimer can play a crucial role in modifying their fibrillation potential. However, although PAMAM did not maintain a-synuclein in a soluble monomeric state, there was an obvious difference in the aggregation pattern when it is present, which is also seen from Figure 2C, is that aggregation of a-synuclein without PAMAM leads to a clear solution, whereas in the presence of PAMAM, an opaque precipitate is produced because of the formation of insoluble amorphous aggregates.…”